95 related articles for article (PubMed ID: 27403316)
1. Reply to letter to the editor: "The dosage of rifabutin in H. pylori eradication regimen should be appropriately determined in each area of the world".
Mori H; Suzuki H
United European Gastroenterol J; 2016 Jun; 4(3):476-7. PubMed ID: 27403316
[No Abstract] [Full Text] [Related]
2. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
[TBL] [Abstract][Full Text] [Related]
3. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.
Gisbert JP; Castro-Fernandez M; Perez-Aisa A; Cosme A; Molina-Infante J; Rodrigo L; Modolell I; Cabriada JL; Gisbert JL; Lamas E; Marcos E; Calvet X
Aliment Pharmacol Ther; 2012 Apr; 35(8):941-7. PubMed ID: 22372560
[TBL] [Abstract][Full Text] [Related]
4. One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin.
Miehlke S; Schneider-Brachert W; Kirsch C; Morgner A; Madisch A; Kuhlisch E; Haferland C; Bästlein E; Jebens C; Zekorn C; Knoth H; Stolte M; Lehn N
Helicobacter; 2008 Feb; 13(1):69-74. PubMed ID: 18205669
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.
Borody TJ; Pang G; Wettstein AR; Clancy R; Herdman K; Surace R; Llorente R; Ng C
Aliment Pharmacol Ther; 2006 Feb; 23(4):481-8. PubMed ID: 16441468
[TBL] [Abstract][Full Text] [Related]
6. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.
Mori H; Suzuki H; Matsuzaki J; Tsugawa H; Fukuhara S; Miyoshi S; Hirata K; Seino T; Matsushita M; Nishizawa T; Masaoka T; Kanai T
United European Gastroenterol J; 2016 Jun; 4(3):380-7. PubMed ID: 27403304
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of rifabutin-based triple therapy in Helicobacter pylori infected patients after two standard treatments.
González Carro P; Pérez Roldán F; De Pedro Esteban A; Legaz Huidobro ML; Soto Fernández S; Roncero Garcia Escribano O; Esteban López-Jamar JM; Pedraza Martin C; Ruíz Carrillo F
J Gastroenterol Hepatol; 2007 Jan; 22(1):60-3. PubMed ID: 17201882
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori: usefulness of an empirical fourth-line rifabutin-based regimen.
D'Elios MM; Silvestri E; Emmi G; Barnini T; Prisco D
Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):437-9. PubMed ID: 22928895
[TBL] [Abstract][Full Text] [Related]
9. Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin.
Toracchio S; Capodicasa S; Soraja DB; Cellini L; Marzio L
Dig Liver Dis; 2005 Jan; 37(1):33-8. PubMed ID: 15702857
[TBL] [Abstract][Full Text] [Related]
10. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2012 Jan; 35(2):209-21. PubMed ID: 22129228
[TBL] [Abstract][Full Text] [Related]
11. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282
[TBL] [Abstract][Full Text] [Related]
12. Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori.
Suzuki S; Suzuki H; Nishizawa T; Kaneko F; Ootani S; Muraoka H; Saito Y; Kobayashi I; Hibi T
Digestion; 2009; 79(1):1-4. PubMed ID: 19142036
[TBL] [Abstract][Full Text] [Related]
13. Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice.
Zullo A; De Francesco V; Manes G; Scaccianoce G; Cristofari F; Hassan C
J Gastrointestin Liver Dis; 2010 Jun; 19(2):131-4. PubMed ID: 20593044
[TBL] [Abstract][Full Text] [Related]
14. Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.
Fiorini G; Vakil N; Zullo A; Saracino IM; Castelli V; Ricci C; Zaccaro C; Gatta L; Vaira D
Clin Gastroenterol Hepatol; 2013 May; 11(5):507-10. PubMed ID: 23267869
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.
Tay CY; Windsor HM; Thirriot F; Lu W; Conway C; Perkins TT; Marshall BJ
Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1076-83. PubMed ID: 23072648
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Miehlke S; Hansky K; Schneider-Brachert W; Kirsch C; Morgner A; Madisch A; Kuhlisch E; Bästlein E; Jacobs E; Bayerdörffer E; Lehn N; Stolte M
Aliment Pharmacol Ther; 2006 Jul; 24(2):395-403. PubMed ID: 16842467
[TBL] [Abstract][Full Text] [Related]
17. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens?
Losurdo G; Iannone A; Giorgio F; Principi M; Di Leo A; Ierardi E
United European Gastroenterol J; 2016 Jun; 4(3):474-5. PubMed ID: 27403315
[No Abstract] [Full Text] [Related]
18. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
Gisbert JP; Gisbert JL; Marcos S; Pajares JM
Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810
[TBL] [Abstract][Full Text] [Related]
19. Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies.
Ciccaglione AF; Tavani R; Grossi L; Cellini L; Manzoli L; Marzio L
Helicobacter; 2016 Oct; 21(5):375-81. PubMed ID: 26807668
[TBL] [Abstract][Full Text] [Related]
20. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
Gisbert JP; Gisbert JL; Marcos S; Jimenez-Alonso I; Moreno-Otero R; Pajares JM
Aliment Pharmacol Ther; 2008 Feb; 27(4):346-54. PubMed ID: 17999716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
